Could Aphria Inc Gain Strenght? The Stock Just Gapped Down

 Could Aphria Inc Gain Strenght? The Stock Just Gapped Down

The stock of Aphria Inc (CVE:APH) gapped down by $0.48 today and has $4.39 target or 3.00% below today’s $4.53 share price. The 5 months technical chart setup indicates high risk for the $389.45 million company. The gap down was reported on Nov, 22 by Barchart.com. If the $4.39 price target is reached, the company will be worth $11.68 million less.
Gaps down are helpful for identifying a resistance level and to could also be used as a tradeable event. If traders are short the stock and it experiece gap down, then its usually advisable to hold the short for a bigger down move. Back-tests of such patterns show that two-thirds of the these patterns the stock performance worsens after the gap. The area gaps close 91% of the time, the breakaway gaps 1%, the continuation gaps 9% and the exhaustion gaps 64%. About 7.78 million shares traded hands or 154.25% up from the average. Aphria Inc (CVE:APH) has risen 6.00% since October 23, 2016 and is uptrending. It has outperformed by 1.44% the S&P500.

More news for Aphria Inc (CVE:APH) were recently published by: Profitconfidential.com, which released: “Aphria Inc: Making Heads or Tails of APH Stock” on November 22, 2016. Midasletter.com‘s article titled: “Marijuana dominates Canada: Supreme Pharmaceuticals, Canopy Growth, Aphria Inc” and published on November 18, 2016 is yet another important article.

Aphria Inc., formerly Black Sparrow Capital Corp., is a Canada company, which is engaged in producing and selling medical marijuana through retail sales and wholesale channels. The company has a market cap of $389.45 million. The Company’s retail sales are primarily sold through the Company’s online store, as well as telephone orders. It has a 187.42 P/E ratio. The Company’s wholesale shipments are sold to other Medical Purposes Regulations Licensed Producers.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment